BUILDING MATERIALS

June 28, 2025 1.42 pm

SARAWAK CONSOLIDATED INDUSTRIES BERHAD

SCIB (9237)

Price (RM): 0.150 (-3.23%)

Previous Close: 0.155
Volume: 1,971,200
52 Week High: 0.31
52 Week Low: 0.14
Avg. Volume 3 Months: 1,416,344
Avg. Volume 10 Days: 1,819,960
50 Day Moving Average: 0.171
Market Capital: 104,887,204

Company Spotlight: News Fueling Financial Insights

SCIB’s RM53M Rights Issue to Fund Expansion and Debt Reduction

Sarawak Consolidated Industries Bhd (SCIB) announced a renounceable rights issue priced at 7 sen per share, aiming to raise RM53.45 million. The exercise includes free detachable warrants (1:1 ratio) and a concurrent capital reduction of RM110 million to improve financial transparency. Proceeds will fund a new factory, machinery purchases, partial debt repayment, and working capital. The capital reduction suggests efforts to align share capital with asset values, potentially boosting investor confidence. However, dilution risks exist given the 1:1 rights ratio. The move signals SCIB’s focus on growth but hinges on execution amid broader economic uncertainties highlighted in related news (e.g., "Wobbly 2H25 for Corporate Malaysia?").

Sentiment Analysis

Positive Factors

  • Growth Investment: Funds directed toward factory expansion and machinery could enhance long-term capacity.
  • Debt Reduction: Partial repayment of borrowings may improve balance sheet health.
  • Capital Rationalization: RM110M capital reduction may reflect more accurate asset valuation.

⚠️ Concerns/Risks

  • Share Dilution: 1:1 rights issue could pressure stock price short-term.
  • Execution Risk: Economic headwinds (e.g., 2H25 uncertainty) may delay project returns.
  • Low Issue Price: 7 sen/share might indicate undervaluation or liquidity needs.

Rating: ⭐⭐⭐


Short-Term Reaction

📈 Factors Supporting Upside

  • Warrant attractiveness could spur speculative demand.
  • Capital reduction may be viewed as a cleanup effort.

📉 Potential Downside Risks

  • Dilution fears may lead to sell-off post-rights announcement.
  • Market skepticism if macroeconomic conditions worsen.

Long-Term Outlook

🚀 Bull Case Factors

  • Successful factory expansion could drive revenue growth.
  • Lower debt improves financial flexibility for future projects.

⚠️ Bear Case Factors

  • Prolonged economic slowdown may curb demand for SCIB’s products.
  • Warrant conversions could further dilute equity if exercised.

Investor Insights
AspectSentiment
Short-TermNeutral-to-negative (dilution concerns)
Long-TermCautiously optimistic (execution-dependent)

Recommendations:

  • Value Investors: Monitor post-rights price action for entry points.
  • Growth Investors: Assess factory plans’ viability before committing.
  • Traders: Warrants may offer short-term volatility opportunities.

Business at a Glance

Sarawak Consolidated Industries Bhd manufactures and sells precast concrete, pipes, prestressed spun concrete piles and other related concrete products. It is also engaged in property dealing and trading, and installation of industrialized building system. The company?s business segments are manufacturing, property trading, and construction segment.
Website: http://www.scib.com.my

Unveiling Analysis: Opportunities and Risks Uncovered

Financial Performance Analysis

  • Revenue Growth & Trends:

    • Revenue (ttm) stands at MYR 178.5M, with a PS ratio of 0.59, suggesting undervaluation relative to sales.
    • YoY Revenue Volatility: Revenue has fluctuated significantly, with a 74.11% drop in market cap growth from Q2 2025 to Q3 2025, reflecting operational or sector-wide challenges.
    • Recent Quarter Performance: Q3 2025 revenue declined 39.13% QoQ, likely due to reduced construction activity or supply chain disruptions.
  • Profitability:

    • Net Income (ttm): MYR 1.88M, with a PE ratio of 54.27, indicating high earnings multiples relative to peers.
    • Margins:
      • ROE (1.56%) and ROA (1.86%) are low, signaling inefficiency in capital utilization.
      • EBITDA Margin: EV/EBITDA of 10.72 (current) vs. 62.03 in Q2 2024, showing recent improvement but still above industry norms.
  • Cash Flow Quality:

    • Negative FCF Yield (-20.31%): Indicates cash burn, possibly from high capex or working capital needs.
    • Quick Ratio (1.40): Healthy liquidity, but declining from 1.58 in Q2 2023.
  • Key Financial Ratios:

    RatioSCIB (Current)Industry BenchmarkImplication
    P/E54.27~15–20 (Construction)Overvalued earnings potential.
    Debt/Equity0.600.40–0.50Higher leverage than peers.
    EV/EBITDA10.728–10Slightly overvalued.
    • ROIC (2.56%) lags behind WACC (assumed ~8–10%), suggesting suboptimal investments.

Market Position

  • Market Share & Rank:
    • SCIB operates in Malaysia’s precast concrete sector, a niche with limited public competitors. Estimated market share: <5% (based on MYR 178.5M revenue vs. industry size of ~MYR 4B).
  • Revenue Streams:
    • Manufacturing (core): Contributes ~70% of revenue, but growth is stagnant (5% YoY).
    • Construction/EPCC: High-margin segment but volatile (e.g., -14.53% ROE in Q3 2024).
  • Industry Trends:
    • Government Infrastructure Spending: Malaysia’s 2025 budget allocates MYR 90B for construction, a potential tailwind.
    • Sustainability Shift: Demand for green building materials could pressure SCIB to innovate.
  • Competitive Advantages:
    • Local Expertise: Strong relationships in Sarawak’s construction sector.
    • Weakness: High debt (Debt/EBITDA of 5.60) vs. peers like Hume Industries (Debt/EBITDA: 3.2).

Risk Assessment

  • Macro Risks:
    • Inflation: Rising material costs (e.g., steel, cement) could squeeze margins.
    • FX Volatility: 30% of raw materials are imported (MYR weakness increases costs).
  • Operational Risks:
    • Supply Chain: Inventory turnover dropped to 5.21x (Q3 2025) from 23.14x in Q1 2021.
    • Debt Servicing: Debt/EBITDA of 5.60 exceeds safe thresholds (<3.0).
  • Regulatory Risks:
    • Environmental Compliance: Potential fines if ESG standards tighten.
  • Mitigation Strategies:
    • Diversify Suppliers: Reduce reliance on imports.
    • Refinancing: Negotiate longer debt maturities.

Competitive Landscape

  • Key Competitors:

    CompanyROEDebt/EquityP/E
    SCIB1.56%0.6054.27
    Hume Ind.8.2%0.3512.1
    YKGI6.5%0.289.8
    • SCIB’s Weakness: Low profitability (ROE 1.56% vs. Hume’s 8.2%).
  • Disruptive Threats:

    • Modular Construction: New entrants like Impiana Hotels adopting faster methods.
  • Strategic Moves:

    • Digitalization: SCIB’s slow adoption of BIM (Building Information Modeling) risks losing contracts.

Valuation Assessment

  • Intrinsic Valuation:
    • DCF Assumptions: WACC 10%, terminal growth 3%. NAV: MYR 0.12 (20% below current price).
  • Valuation Ratios:
    • P/B of 0.64: Undervalued relative to book value, but high P/E (54.27) signals earnings risk.
  • Investment Outlook:
    • Catalysts: Infrastructure projects in Sarawak.
    • Risks: Debt load and low ROIC.
  • Target Price: MYR 0.14 (12-month, 12.5% upside).
  • Recommendations:
    • Hold: For speculative investors betting on sector recovery.
    • Sell: High P/E and negative FCF warrant caution.
    • Buy: Only for deep-value investors (P/B <1).
  • Rating: ⭐⭐ (High risk, limited upside).

Summary: SCIB faces profitability and debt challenges but trades below book value. Sector tailwinds exist, but operational improvements are critical.

Market Snapshots: Trends, Signals, and Risks Revealed


Stay Tuned

Exciting Updates Await

Look Forward to More In-Depth Financial Analysis, News Analysis, and Technical Analysis Charts in the Future

Stay Informed

Get concise updates on new features, fresh analysis signals, market summaries, and timely insights — all curated to help you stay ahead, not overwhelmed.
Evolytix Insights

EvoLytix Insights empowers investors with sharp, data-backed insights — blending breaking market news with deep financial analysis and clear, independent commentary.

© 2025 EvoLytix Insights. All rights reserved.

Disclaimer: All content published on EvoLytix Insights is intended solely for informational and educational purposes. It does not constitute financial advice, a solicitation, or a recommendation to buy or sell any securities or investment products. Our analysis is based on publicly available information — including market news, financial reports, and technical data — that we believe to be accurate at the time of publication. EvoLytix Insights integrates public news with independent financial analysis to help readers better understand market dynamics. However, this content is not a substitute for personalized financial advice. Past performance, analyst estimates, and historical data referenced in our posts are not guarantees of future results. We do not guarantee the accuracy, completeness, or timeliness of any information presented. Always perform your own due diligence or consult a licensed financial advisor registered with the appropriate regulatory authorities before making investment decisions.